Connective Tissue Growth Factor in Drug-Induced Gingival Overgrowth

Journal of Periodontology

Volumn 72, Issue 7, 2001, Pages 921-931

  Ilhan Uzel, M ^a   Kantarci, Alpdogan ^a,b   Hong, Hsiang Hsi ^a   Uygur, Cem ^b   Sheff, Michael C ^c   Firatli, Erhan ^b   Trackman, Philip C ^a  

^a BOSTON UNIVERSITY   (United States)

^b ISTANBUL UNIVERSITY   (Turkey)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Gingival hyperplasia etiology; Growth factors, connective tissue; Growth factors, transforming

Indexed keywords

ANTIBODY; ANTICONVULSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARRIER PROTEIN; CD31 ANTIGEN; COLORING AGENT; CONNECTIVE TISSUE GROWTH FACTOR; CYCLOSPORIN; DIAGNOSTIC AGENT; GROWTH PROMOTOR; IMMEDIATE EARLY PROTEIN; IMMUNOSUPPRESSIVE AGENT; MITOGENIC AGENT; NIFEDIPINE; PHENYTOIN; SIGNAL PEPTIDE; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CONNECTIVE TISSUE; ENZYME IMMUNOASSAY; EPITHELIUM; FEMALE; FIBROBLAST; FIBROSIS; GINGIVA OVERGROWTH; HUMAN; IMAGE PROCESSING; MALE; MIDDLE AGED; MONONUCLEAR CELL; NEOVASCULARIZATION (PATHOLOGY); NONPARAMETRIC TEST; PATHOLOGY; VASCULAR ENDOTHELIUM;

ADULT; ANTIBODIES; ANTICONVULSANTS; ANTIGENS, CD31; CALCIUM CHANNEL BLOCKERS; CARRIER PROTEINS; COLORING AGENTS; CONNECTIVE TISSUE; CYCLOSPORINE; ENDOTHELIUM, VASCULAR; EPITHELIUM; FEMALE; FIBROBLASTS; FIBROSIS; GINGIVAL OVERGROWTH; GROWTH SUBSTANCES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMEDIATE-EARLY PROTEINS; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MITOGENS; NEOVASCULARIZATION, PATHOLOGIC; NIFEDIPINE; PHENYTOIN; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0035406280     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2001.72.7.921     Document Type: Article

References (57)

1. Kimball OP. The treatment of epilepsy with sodium diphenyl hydantoinate. JAMA 1939;112:1244-1245.
2. Rateitschak-Pluss E, Hefti A, Lortscher R, Thiel G. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;10:237-246.
3. Lederman D, Lumerman H, Reuban S, Freeman P. Gingival hyperplasia associated with nifedipine therapy. Oral Surg Oral Med Oral Pathol 1984;57:620-622.
4. Ramon Y, Behar S, Kishon Y, Engelberg I. Gingival hyperplasia caused by nifedipine - a preliminary report. Int J Cardiol 1984;5:195-204.
5. Marshall RI, Bartold PM. A clinical review of drug-induced gingival overgrowths. Aust Dent J 1999;44:219-232.
6. Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000;27:217-223.
7. McLaughlin WS, Ball DE, Seymour RA, Kamali F, White K. The pharmacokinetics of phenytoin in gingival crevicular fluid and plasma in relation to gingival overgrowth. J Clin Periodontol 1995;22:942-945.
8. Cebeci I, Kantarci A, Firatli E, et al. Evaluation of the frequency of HLA determinants in patients with gingival overgrowth induced by cyclosporine-A. J Clin Periodontol 1996;23:737-742.
9. Cebeci I, Kantarci A, Firatli E, Carin M, Tuncer O. The effect of verapamil on the prevalence and the severity of cyclosporine-induced gingival overgrowth in renal allograft recipients. J Periodontol 1996;67:1201-1205.
10. Ball DE, McLaughlin WS, Seymour RA, Kamali F. Plasma and saliva concentrations of phenytoin and 5-(4-hyroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients. J Periodontol 1996;67:597-602.
11. Thomason JM, Seymour RA, Ellis JS, et al. Determinants of gingival overgrowth severity in organ transplant patients: an examination of the role of HLA phenotype. J Clin Periodontol 1996;23:628-634.
12. Cebeci I, Kantarci A, Gurel N, et al. Analysis of peripheral blood leukocytes in patients with cyclosporine A-induced gingival hyperplasia. J Periodontol 1998;69: 1435-1439.
13. Kantarci A, Cebeci I, Tuncer O, Carin M, Firatli E. Clinical effects of periodontal therapy on the severity of cylosporin A-induced gingival hyperplasia. J Periodontol 1999;70:587-593.
14. Goultschin J, Shoshan S. Inhibition of collagen breakdown by diphenylhydantoin. Biochim Biophys Acta 1980;631:188-191.
15. Dahllof G, Reinholt FP, Hjerpe A, Modeer T. A quantitative analysis of connective tissue components in phenytoin-induced gingival overgrowth in children. J Periodont Res 1984;19:401-407.
16. Salo T, Oikarinen KS, Oikarinen AI. Effect of phenytoin and nifedipine on collagen expression in normal human gingival fibroblasts. J Oral Pathol Med 1990;19:404-407.
17. Modeer T, Mendez C, Dahllof G, Anduren I, Andersson G. Effect of phenytoin medication on the metabolism of epidermal growth factor receptor in cultured gingival fibroblasts. J Periodont Res 1990;25:120-127.
18. McKewitt KMB, Irwin CR. Phenotypic differences in growth, matrix synthesis and response to nifedipine between fibroblasts derived from clinically healthy and overgrown gingival tissue. J Oral Pathol Med 1995;24:66-71.
19. Romanos GE, Shroter-Kermani C, Hinz N, Bernimoulin J-P. Distribution of fibronectin in healthy, inflamed and drug-induced gingival hyperplasia. J Oral Pathol Med 1992;21:256-260.
20. Romanos GE, Shroter-Kermani C, Hinz N, Herrmann D, Strub JR, Bernimoulin J-P. Extracellular matrix analysis of nifedipine-induced gingival overgrowth: immunohistochemical distribution of different collagen types as well as the glycoprotein fibronectin. J Periodont Res 1993;28:10-16.
21. Tipton DA, Fry HR, Dabbous MK. Altered collagen metabolism in nifedipine-induced gingival overgrowth. J Periodont Res 1994;29:401-409.
22. Newell J, Irwin CR. Comparative effects of cyclosporin on glycosaminoglycan synthesis by gingival fibroblasts. J Periodontol 1997;68:443-447.
23. 1. J Periodont Res 1998;33:40-48.
24. Plemons JM, Dill RE, Rees TD, Dyer BJ, Ng MC, Iacopino AM. PDGF-B producing cells and PDGF-B gene expression in normal gingival and cyclosporine A-induced gingival overgrowth. J Periodontol 1996;67: 264-270.
25. Saito K, Mori S, Iwakura M, Sakamoto S. Immunohistochemical localization of transforming growth factor β, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin. J Periodont Res 1996;31:545-555.
26. Iacopino AM, Doxey D, Cutler CW, et al. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol 1997;68:73-83.
27. Bradham DM, Igarashi A, Potter RL, Grotendorst GR. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991;114:1285-1294.
28. Ryseck R-P, MacDonald-Bravo H, Mattei M-G, Bravo R. Structure, mapping and expression of fisp-12, a growth factor-inducible gene encoding a cysteine-rich protein. Cell Growth Differ 1991;2:225-233.
29. Brigstock, DR. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 1999;20:189-206.
30. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996; 107:404-411.
31. Igarashi A, Nashiro K, Kikuchi K, et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 1995; 105:280-284.
32. Ito Y, Aten J, Bende RJ, et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998;53:853-861.
33. Lasky JA, Ortiz LA, Tonthat B, et al. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am J Physiol 1998;275: L365-L371.
34. Paradis V, Dargere D, Vidaud M, et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatol 1999;30:968-976.
35. di Mola FF, Friess H, Martignoni ME, et al. Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg 1999;230:63-71.
36. Mori T, Kawara S, Shinozaki M, et al. Role and interaction of connective tissue growth factor-β in persistent fibrosis: a mouse fibrosis model. J Cell Physiol 1999;181: 153-159.
37. Shimo T, Nakanishi T, Nishida T, et al. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cell in vitro, and angiogenesis in vivo. J Biochem 1999;126:137-145.
38. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993;4:637-645.
39. Dammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S. Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol 1998;30:909-922.
40. Duncan MR, Fraizer KS, Abramson S, et al. Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: down-regulation by cAMP. FASEB J 1999;13:1774-1786.
41. Dammeier J, Beer H-D, Brauchle M, Werner S. Dexamethasone is a novel potent inducer of connective tissue growth factor expression. J Biol Chem 1998;273: 18185-18190.
42. Hong H-H, Uzel MI, Duan C, Sheff MC, Trackman PC. Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-β1 and detection in human gingiva. Lab Invest 1999;79:1655-1667.
43. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21: 533-551.
44. Yu X, Graves DT. Fibroblasts, mononuclear phagocytes, and endothelial cells express monocyte chemoattractant protein-1 (MCP-1) in inflamed human gingival. J Periodontol 1995;66:80-88.
45. Yu X, Antoniades HN, Graves DT. Expression of monocyte chemoattractant protein 1 in human inflamed gingival tissues. Infect Immun 1993;61:4622-4628.
46. Shin G-T, Khanna A, Ruchuang D, Sharma VK, Lagman M, Li B, Suthanthiran M. In vivo expression of transforming growth factor-β1 in humans; stimulation by cyclosprine. Transplantation 1998;65:313-318.
47. Shihab FS, Andoh TF, Tanner AM, et al. Role of transforming growth factor β1 in experimental chronic cyclosporine nephropathy. Kidney Inter 1996;49:1141-1151.
48. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-β action on fibroblasts. Cytokine Growth Factor Rev 1997;8:171-179.
49. Polverini PJ. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 1995;6:230-247.
50. Furcht LT. Critical factors controlling angiogenesis: cell products, cell matrix, and growth factors. Lab Invest 1986;55:505-509.
51. Oemar BS, Werner A, Gamier JM, et al. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 1997;95:831-839.
52. Shimo T, Nakanishi T, Kimura Y, et al. Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. J Biochem 1998;124:130-140.
53. Simmons DL, Walker C, Power C, Pigott R. Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J Exp Med 1990;171:2147-2152.
54. Albelda SM, Muller WA, Buck CA, Newman PJ. Molecular and cellular properties of PECAM-1 (endoCAM/ CD31): a novel vascular cell-cell adhesion molecule J Cell Biol 1991;114:1059-1068.
55. Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-1124.
56. Berger R, Albelda SM, Berd D, et al. Expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) during melanoma-induced angiogenesis in vivo. J Cuten Pathol 1993;20:399-406.
57. Pazouki S, Chisholm DM, Adi MM, et al. The association between tumour progression and vascularity in the oral mucosa. J Pathol 1997;183:39-43.